Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 124.00
+11.00 (9.73%)
Sep 8, 2026, 1:24 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 18.37 billion as of September 4, 2026. Its market cap has increased by 42.44% in one year.
Market Cap
18.37B
Enterprise Value
14.68B
Revenue
1.21B
Ranking
n/a
PE Ratio
37.44
Stock Price
124.00
ChartMarket Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 18.37B, an increase of 120.77%. That is a compound annual growth rate of 8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 18.37B | 35.74% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 49.08B |
| Center Laboratories | 23.85B |
| TTY Biopharm Company | 19.15B |
| Synmosa Biopharma | 16.08B |
| ScinoPharm Taiwan | 15.10B |
| YungShin Global Holding | 14.94B |
| Grape King Bio | 13.41B |
| Foresee Pharmaceuticals | 12.60B |